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Molecular dynamicsCADY is a cell-penetrating peptide spontaneously making non-covalent complexes with Short interfering
RNAs (siRNAs) in water. Neither the structure of CADY nor that of the complexes is resolved. We have calcu-
lated and analyzed 3D models of CADY and of the non-covalent CADY–siRNA complexes in order to under-
stand their formation and stabilization. Data from the ab initio calculations and molecular dynamics
support that, in agreement with the experimental data, CADY is a polymorphic peptide partly helical. Taking
into consideration the polymorphism of CADY, we calculated and compared several complexes with peptide/
siRNA ratios of up to 40. Four complexes were run by using molecular dynamics. The initial binding of CADYs is
essentially due to the electrostatic interactions of the arginines with siRNA phosphates. Due to a repetitive argi-
ninemotif (XLWR(K)) in CADY and to the numerous phosphatemoieties in the siRNA, CADYs can adoptmultiple
positions at the siRNA surface leading to numerous possibilities of complexes. Nevertheless, several complex
properties are common: an average of 14±1 CADYs is required to saturate a siRNA as compared to the 12±2
CADYs experimentally described. The 40 CADYs/siRNA that is the optimal ratio for vector stability always corre-
sponds to two layers of CADYs per siRNA. When siRNA is covered by the ﬁrst layer of CADYs, the peptides still
bind despite the electrostatic repulsion. The peptide cage is stabilized by hydrophobic CADY–CADY contacts
thanks to CADY polymorphism. The analysis demonstrates that the hydrophobicity, the presence of several pos-
itive charges and the disorder of CADY are mandatory to make stable the CADY–siRNA complexes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The therapeutic application of molecules such as peptides, proteins,
drugs and nucleic acids is directly related to their plasma membrane
permeability and to their capacity to reach biological targets within
cells [1]. siRNAs speciﬁcally control protein activation and/or gene ex-
pression post-transcriptionally and have thus important therapeutic
potentialities. They are of amajor interest for future therapies in several
diseases, including cancer [2,3] and the main obstacle to their clinical
applications, as in most nucleic acid-based strategies, remains their
poor cellular uptake and bioavailability [4,5]. Among the different car-
riers that were developed to facilitate membrane translocation of ther-
apeutic molecules (liposomes, biopolymers, retroviruses, …), Cell
Penetrating Peptides (CPPs) are very promising [6,7]. CPPs are
highly-charged and relatively short (less than 30 residues). Two classes
of CPP–cargo complexes have been described resulting in either a cova-
lent link between the CPP and its cargo, or the non-covalent interactionsrights reserved.of several CPPswith a cargo [7,8]. The latter offers the advantage to sim-
plify the protocol of conjugation since there is no need for a chemical
linkage; it also reduces the likelihood of CPP interference with the bio-
logical activity of the therapeutic molecule since therapeutic effects
likely require the free form of the cargo [1]. Recently, the non-
covalent strategy based on MPG/CADY amphipathic peptides has been
successfully applied for both in cellulo and in vivo siRNA delivery
[9,10] and was extended to CPPs originally used to make conjugates
[11,12].
The non-covalent CPPs, CADY, MPG and PEP-1, associate rapidly
with their cargo by combining both electrostatic and hydrophobic
interactions to form stable complexes [7,10,13–17]. For MPG and
PEP1, optimal biological responses are observed for a peptide–
cargo molar ratio between 10/1 and 25/1 [9,14,18,19]. CD and FTIR
experiments have demonstrated that CADY is mainly random coil
in water and more α-helical in the presence of its siRNA cargo [14]
while Pep-1 andMPG are random coil in water at low concentrations
and remain so in the presence of their cargo [15]. CADY is monomeric
in solution and possesses a cysteamide residue on its C-terminal end
like MPG. This residuewas originally added to enable the attachment
Table 1
CADY and siRNA sequences.
Molecule Sequence
CADY Ac-GLWRALWRLLRSLWRLLWKA-cysteamide
19 bp siRNA (2ZI0) (siRNA1) 5′ AGACAGCAUUAUGCUGUCU 3′ (sense strand)
siRNA anti-cyclin B1 (siRNA2) 5′ GAAAUGUACCCUCCAGAAATT 3′ (sense strand)
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uptakes [20].
Cellular uptakes of the CPP–cargo complexeswere long thought to be
independent of endocytosis, requiring no energy. However, Richard et al.
highlighted the artifacts in earlier studies and proposed a mechanism
associated with the endosomal pathway [21]. Nowadays, although the
cellular uptake mechanism of most covalent cargo–CPP complexes is
believed to involve endosomal routes, the mechanisms remain unclear
for the non-covalent cargo–CPP complexes [15,22,23]. Numerous studies
have shown that the cell permeability of these non-covalent CPP–cargo
complexes does not necessarily involve the endosomal pathway and
that they can enter cells by different ways including a direct uptake
which depends on their nature and local concentration [15,24].
The permeability problem could be different for free CPPs. Mecha-
nisms of direct translocation have been proposed such as the “carpet
model” [25], transient pore formation [26] or reverse micelle formation
[27]. Recently, molecular dynamics studies of the interactions of
Penetratin, TP10, TAT and poly-arginine peptides with lipid bilayer
have been described [28–30]. Herce et al. carried out all-atom simula-
tions of the HIV-1 TAT peptide in the presence of a membrane and pro-
posed a mechanism of translocation in four steps including the
formation of a transient water pore and the diffusion of peptides at
the pore surface to cross the membrane [28,31]. An alternative mecha-
nism was proposed by Yesylevskyy et al. in which Penetratin and TAT
peptides enter cells by macropinocytosis. The peptides induce a mem-
brane curvature ultimately leading to the encapsulation of a peptide
cluster [29].
The structure of the non-covalent CPP–cargo complexes has been
studied by dynamic light scattering and electron microscopy and
nanoparticles with sizes between 70 and 200 nm were observed
[14,15,18,23]. Gaining further information on the structures of the
non-covalent complexes should be valuable in the understanding of
their complex formation and their translocation through themembranes.
The present work focuses on the secondary amphipathic
CADY-peptide and on its capacity to spontaneously form non-covalent
complexes with siRNA in water. These complexes promote the nucleic
acid internalization and a biological response in cellulo [10]. We start
by calculating the 3D models of CADY because no experimental model
has been resolved. In 2006, we developed PepLook, a Boltzmann
stochastic algorithm, to calculate the structure of peptides from se-
quences [32]. The conformation of CADY was reported to vary with
the media [14] and structural polymorphism was demonstrated to
be important for the activity and permeability of some CPPs
[33,34]. Special attention is paid to polymorphism in PepLook
since, besides the best 3D model named the Prime that was shown
to be comparable to NMR models [32], the population of low energy
models is also sorted enabling to evaluate the peptide structural
polymorphism.
When disordered peptides build up complexes, their initial diver-
sity of structures may lead to different solutions of binding or, the
binding step can select one conformation. To take the problem into
account we calculated several CADY–siRNA complexes from differ-
ent models of CADY and compared them. To calculate complexes,
we used a screening docking procedure. In 1986, Brasseur et al. de-
veloped Hypermatrix to analyze the interaction of peptides with
lipids [35–38] and was recently used to compare the mechanism of
interaction of the derived-CRAC motifs with cholesterol [39,40]. Efﬁ-
cient CRAC motifs were shown to pinch the polar OH head of choles-
terol, saturating its H-donor and H-acceptor capacities and impairing
its polar interactions with phosphatidylcholine. In the present work,
the initial Hypermatrix procedure in the membrane was modiﬁed to
dock molecules in the 3 dimensions of a homogenous medium as
water. Last, several complexes were relaxed by all-atom molecular
dynamics using GROMACS [41]. Cargo–CPP complexes were ana-
lyzed and compared to predict the main rules of their formation
and stability.2. Material and methods
2.1. Peptide and siRNA models
CADY is a 20 residue peptide (Table 1)with its N and C-ends blocked
by an acetyl and a cysteamidemoiety, respectively.We used two siRNAs
(Table 1). The ﬁrst one is the PDB model from 2ZI0 and will be named
siRNA1. The second corresponds to the anticyclin B1 siRNA (siRNA2)
and it was calculated using Coot in a double helix A [42]. siRNA2 pos-
sesses two ﬂipping thymines at both ends.
Different 3D models of CADY have been calculated. First, an α-helix
was constructed andminimized by conjugate gradient usingHyperChem
5.0 (Hypercube Inc.). Then, two models were calculated with PepLook
[32]. Brieﬂy, the 3D models are built from the sequence by introducing
backbone angle values randomly drawn from a set of 64 couples of
phi/psi angles derived from a database of protein PDB models. At each
step, 2·105 different models are calculated and their energy is used for
ranking. Backbone angle values that give either good or bad solu-
tions are identiﬁed. The relative probability of picking up one of
the 64 phi/psi values for a residue is then modulated according to
its chances of inducing good or bad conformations in the previous
steps. Calculations are automatically stoppedwhen the pattern of prob-
ability of the phi-psi angles remains constant for at least ﬁve steps. The
bestmodel is the Prime and the 50models of lower energy are sorted to
characterize the peptide polymorphism.
Models are all-atoms and their energies are computed as described
in Thomas et al. [32] taking into account all interactions between
non-bound atoms with a cut off of 2 nm. Energy terms are Van der
Waals (Lennard-Jones), electrostatic (coulomb with an exponentially
variable dielectric constant from 1 to 80) and two hydrophobicity
terms, one for intra and intermolecular atom interactions and the sec-
ond for solvent effect. The ﬁrst terms use atom transfer energy (Etr)
and atom distances, the second one uses atom accessible surface area
and atom Etr in the corresponding solvent, as previously described
[32,43].
The two PepLook models used in the study were the Prime models
calculated in two different external media: a homogenous water sol-
vent and a water/charged lipid plane interface (50% DOPC:50% DOPG).
For complex formation, themodel of CADY predicted at a charged inter-
face was used as the best starting structure for the complex computa-
tion regarding the peptide conformation. For the interface conditions,
at each PepLook step, all models are tested for 1000 orientations at 9
positions i.e. every Å of a 9 Å thick slab interface [44]. The minimal en-
ergy restraint value of insertion in the interface is added to the model
energy value to rank the models.
2.2. CADY–siRNA complexes
The procedure for calculating the siRNA–CADY complexes is mod-
iﬁed from the Hypermatrix 2D procedure in membranes [35–37] to
dock molecules in 3 dimensions. An immobile molecule is the target
and a partner initially set at 360 different positions equally spaced
around the target mass center is moved (translations and rotations)
around. The energy of partner interactions is calculated at each posi-
tion. The immobile target was one of the 3D models of siRNAs, and
moving partners were the 3D models of CADY. We used three models
of CADY; the PepLook Primes of CADY calculated in water and in the
interface and, the α helix model of CADY.
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1 Å up to 80–100 Å. At each step, 90 rotations of CADY are made
with a maximal magnitude of 360°. The energies of partner interac-
tions are calculated. The energy and relative positions of all com-
plexes are stored and complexes are calculated by the sequential
addition of CADYs to form low-energy systems.2.3. Molecular dynamics
For molecular dynamics computations, we used the GROMACS
and the AMBER 99 force ﬁelds [45] to which we had to add a descrip-
tion of the cysteamide residue (CYA) derived from the cysteine resi-
due. Molecular dynamics were performed for the interfacial Prime
model of PepLook and the helix model of CADY and for the four
Hypermatrix complexes made with siRNA2 as detailed in Table 2.
All systems were solvated with TIP3P water and neutralized with
Na+ or Cl−. The size of the triclinic boxes was deﬁned to let at least
1 nm between the solute and the box. All systems were ﬁrst mini-
mized by 2000 steps of the steepest descent and then run for 50 ps
of simulation with the peptides and the siRNA under position re-
straints in periodic boundary conditions (PBC) using a 2 fs time
step. Dynamics were carried out in NPT conditions (310 K and
1 bar). Temperature and pressure were maintained using the bath
method of Berendsen [41]. Electrostatic interactions were treated
using the particle mesh Ewald (PME) method [46], and Van der
Waals interactions were treated with the shift method. All cutoffs
were set to 1.4 nm. Bonds were maintained with the SHAKE algo-
rithm [47]. Positions and velocities of atoms in the system were
saved every 10 ps. All computations, corresponding to a total time
of 465 ns, were performed on three computers with Intel bi-Xeon
quad core (2.33 GHz). The trajectories were performed and analyzed
with GROMACS 3.3.3 tools. The results of the ﬁrst runs are described
and differences observed in the repeats, if any, are speciﬁed in the
text.2.4. MHP (molecular hydrophobicity potential)
MHP is a three-dimensional plot of the hydrophobicity isopotential
surface of a molecule or of a group of molecules. The plot is created to
visualize the system amphipathy as described by Brasseur in 1991
[48] and is calculated by summing the contribution of all atoms. Hydro-
phobicity at a point of space is derived from atom Etr and decreases
exponentially with the distance between the surface of the atom and
this point [48]. In the MHP plots, surfaces joining all points of ±
0.418 kJ are drawn, green for the hydrophilic potential, brown for the
hydrophobic potential.Table 2
List of molecular dynamic simulations.
Simulation
name
System composition Box size
(nm3)
Number of
simulations
Simulation
times (ns)
H1-3 CADY (α helix)/water3168/
Cl−5
5×5×4 3 50
P1-3 CADY (interfacial PepLook)/
water3811/Cl−5
4×6×5 3 50
CH1 siRNA2/CADY (α helix)13/
water23062/Cl−25
12×8×8 1 50
CH2 siRNA2/CADY (α helix)38/
water46539/Cl−150
13×11×11 1 20
CP1 siRNA2/CADY (PepLook)14/
water26258/Cl−30
12×9×8 1 50
CP2 siRNA2/CADY (PepLook)36/
water42784/Cl−140
12×11×11 1 202.5. Properties of molecules and complexes
All molecules and complexes were analyzed using Pex [49] to
detect residues in interaction, to calculate accessible and contact
surfaces (hydrophobic and hydrophilic), lengths and volumes of com-
plexes, and the energy of residues in interaction. Accessible Surface
Area (ASA) was calculated using the method of Shrake and Rupley
(162 dots) and a water molecule radius of 1.4 Å as previously
reported [50,51]. To characterize peptide−siRNA and peptide−peptide
interactions, atomic contacts were counted by using a distance cut off
between atom centers of 0.35 nm. A single contact, the shortest, was
accepted per pair of residues of different chains. Contacts were classi-
ﬁed according to the type of amino acid, to theirmapping in nucleotides
(phosphate, sugar, base) and in amino acids (backbone, side chains)
and to their types (salt bridges, hydrogen bonds, hydrophobic contacts
and Van der Waals). These types were deﬁned as in Lejeune et al. in
2005 [52]. The interactions are salt bridgeswhen nucleotide phosphates
interact with R guanidinium or K amino groups; they are H-bonds,
when OH or NH interacts with O or N; hydrophobic contacts, when a
hydrogen bound to a carbon or a carbon not involved in a carboxyl is
involved in interactions; the Van der Waals type was assigned to the
other contacts. The program CaPTURE (Gallivan) (Cation–π Trends
Using Realistic Electrostatics)was used to identify interactions between
the cationic group of lysine and arginine and the aromatic ring of
tryptophan.
2.6. Binding energies
Three parameters are calculated, Mean Force Potential (MFP; ΔG),
electrostatic energy (ΔE) and partner contact surface areas. Energy
gains are calculated taking into account all molecules (solutes and
water). They concern direct atom contact with a cut off of 0.6 nm
for coulomb term (ΔE) and, more interactions with a larger cut off
of 1 nm for Mean Force Potential (MFP) values (ΔG) to take into
account the hydrophobic collapse as detailed in Thomas et al. in
2010 [53].
Three systems are evaluated; the solvated complex and the two
solvated substrate partners. Molecules are solvated by 3 layers of
all-atom water molecules with a dipole moment of 1.85 Dunits. For
the siRNA/CADY interactions, the complex is the siRNA–CADY com-
plex, substrate partners are the siRNA and the whole CADY cage,
respectively. For the CADY cage, the complex is the cage with no
siRNA, substrate partners are every CADY and the cage made by the
other CADYs, respectively. The model of CADY before dynamics is
used as a substrate to take into account CADY structural changes.
The energies of interaction are half the difference between the com-
plex energy and the sum of the two substrate partners' energy. The
contact surface area between partners is half the difference between
the sum of the water accessible surface area (ASA) of the two partners
minus the water ASA of the complex.
3. Results
3.1. Free CADY and siRNA
3.1.1. CADY
The sequence of CADY has three particularities (Table 1); ﬁrst, the
presence of numerous bulky residues with especially four trypto-
phans (W3, W7, W14, W18) whereas the few small residues (G1,
A5 and A20) are on peptide extremities. The second particularity is
the high number of charges with ﬁve positively-charged residues
(R4, R8, R11, R15 and K19). Moreover, cation–π interactions can be
formed between the cationic group of lysine or arginine and the aro-
matic rings of tryptophan. The third is the occurrence of a motif of
four residues (XLWR(K), X being G, A, S and L) repeated four times.
Due to the regularity of the motif, an α helix structure optimally
Fig. 2. Dynamics of CADY in water. (A) Variation of RMSD calculated onα-carbons after
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bic ones (W and L) but at the same time, the helix gets charged
side-chains spatially close leading to an electrostatic repulsion.
The 50 PepLook models of lower energy of CADY in water (Fig. 1A)
have close MFP values with an average of −147±8 kJ/mol, well
under the −272 kJ/mol per aa stability value of proteins as usual
for peptides [53]. Their secondary structures are mainly random coil
with a short helical fragment in the center or the N-side of the pep-
tide. This is all, as far as similarities are concerned since ﬁtting the
50 models on the Prime (the best model) gives an averaged Cα
RMS deviation of 4.3±0.8 Å indicating a large diversity of three-
dimensional conﬁgurations. These data support the conclusion that
CADY in water is poorly helical and exists as a disordered population
since structurally-different conformations have close MFP values. It
has been previously shown by circular dichroism that CADY is ran-
dom coil in water and adopts a more helical conformation in the pres-
ence of DOPG or DOPC vesicles and of siRNA [10,14,54]. An increase in
helicity is also true in PepLook. When calculations are made in the
negatively-charged interface, the 50 models of CADY (Fig. 1B) are
more helical with an optimal helicity around 60% in the ten best
models. The calculation in the interface goes with a restriction of
the structural diversity since the RMS deviation of the 50 interfacial
models is reduced to 3.6±1 Å.
The evolution of free CADY was analyzed for 50 ns runs of molec-
ular dynamics in water (Table 2). The RMSD vary rapidly to reach a
plateau at 0.6 and 0.8 nm after 20 ns for the helix and the interfacial
PepLook models, respectively (Fig. 2A). To make these U shapes, few
hydrophobic residues, leucines and also tryptophans get spatially
close building small hydrophobic cores. Charged residues are turned
outside (Fig. 3) and can form cation–π stacking with tryptophans
(in average for 50% of W). To follow the formation of the U shape,
the distance between the Cα of the ﬁrst and last leucines of CADY
(L2 and L16) has been recorded (Fig. 2C). With the helix model ofFig. 1. Models of CADY. (A) Left: the 20 best PepLook models in water were ﬁtted on
the Prime (best model). Fitting is made on the central RLLR fragment. Right: the molec-
ular hydrophobicity isopotential (MHP) surfaces (±0.4 kJ) of the Prime. Green surface
is hydrophilic, brown is hydrophobic. (B) Models calculated at a DOPG:DOPC mem-
brane interface with PepLook, legend is the same as for A. (C) Helix model, on the
left the ribbon and stick representation, on the right the MHP surfaces.
a least-square ﬁt on the initial structures. (B) Number of residues in helix (average
over 21 steps) computed with DSSP along the trajectories. (C) Variation of the distance
between the Cα of L2 and L16. Results are presented for the ﬁrst molecular dynamic
carried on with the helical model (H1) and the interfacial PepLook model (P1) of CADY.CADY a U shape is also rapidly formed and then, opens and closes
back between 10 and 20 ns. The disorder of CADY noticed in the
structural diversity of PepLook low energy models is illustrated in
the dynamics by the instability of CADY and by the different best
models obtained from separate runs (Fig. 3). One point is however
to be noticed, although highly charged, CADY in water looks always
hydrophobic. The isopotential surface around CADY demonstrates
this hydrophobicity (Fig. 1). We have previously shown that soluble
proteins have equivalent hydrophobic and hydrophilic surfaces [14].
3.1.2. siRNA
Where CADY is positively charged, siRNAs are negatively charged
with 36–40 phosphate moieties. Unlike CADY, siRNAs are very hydro-
philic with ratios of hydrophobic to hydrophilic water-accessible sur-
face of 0.24 and 0.4 for siRNA2 and siRNA1, respectively. siRNA1 is
extracted from a complex with four helical peptides in which two
peptides are bound in the siRNA groove that is wider than the groove
of the siRNA2 explaining the difference of hydrophobicity. Globally,
free siRNAs are cylinders of about 2×5–8 nm with a water accessible
surface around 80 nm2. siRNA2 has been studied by molecular
dynamics (data not shown) and has similar movements in the solu-
tion as in the complex. These results are presented below.
3.2. CADY–siRNA complexes
In bench assays, siRNA and CADY form a complex in low salt water
solutions using a molar ratio of 1 nucleic acid for up to 40–80 pep-
tides. In silico, we calculated the binding of CADYs to a molecule of
Fig. 3. CADY structures at the end of the molecular dynamics. The models obtained at
the end of the three runs that started from (A) the helical model (H1 to H3) and (B) the
interfacial Peplook model (P1 to P3) are presented. They are ﬁtted on the RLLR back-
bone fragment as in Fig. 1 and shown as a backbone cartoon of three different colors
to highlight the U shape. Then every model is detailed (right and under) to show the
protruding charged residues (sticks) and the residues involved in the core (orange
spheres). These residues are leucines and, when indicated, tryptophanes.
Fig. 4. Variation of siRNA and CADY water accessible surfaces in a complex. The com-
plex was made by the addition of the interfacial PepLook model of CADY to the
siRNA1. Black squares represent the siRNA surface area buried by the addition of
CADYs. White squares are the CADY accessible surface area buried by CADY–CADY
contacts.
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up to 40 CADYs per siRNA.
Since CADY exists as a population of conformers, chances are low
that all models that will bind will have the same conformation. To test
whether this point is important, we used different 3D models of
CADYs and compared the resulting complex structure and energy of
interactions. As mixtures are experimentally prepared in water or in
diluted phosphate buffers, the PepLook Prime model of CADY in
water was used for one series. CADY is known to change the confor-
mation in the presence of siRNA and membranes, i.e. when it faces a
charged interface [14]; thus the PepLook amphipathic model of
CADY calculated in a charged membrane interface was used in a sec-
ond series. Further considering the experimental fact that helicity of
CADY increases in the presence of siRNA [14], we also calculated the
complexes using α helix model of CADY. CADY can bind any siRNA
and, in our assays targets of CADYs were the two models of siRNAs
described before. Then we calculated six different molecular com-
plexes by using three models of CADY and two different siRNAs. The
formation of complexes was followed by the evolution of the accessi-
bility of partners.3.2.1. Decrease of siRNA and CADY accessible surface in complexes
In Fig. 4, the accessible surface of siRNA progressively decreases
with the addition of CADYs and remains constant when 15–17
CADYs are bound. The proﬁle was similar for all the complexes
although the number of peptides needed to reach the plateau varied
from 13 to 17 (mean is 14±1). It suggests that an average of 14±1
CADYs can have a direct access to the molecule of siRNA. Partial burial
of CADYs in complexes also occurs, but with a different course. The
binding of the ﬁrst 5–7 CADYs results in a low decrease of their acces-
sible surface to water. These ﬁrst CADYs are bound to siRNA and dis-
persed on the nucleic acid surface. The addition of more peptides
results in a linearly constant decrease in the CADY accessible surface
especially after the binding of the ﬁrst 15–17 peptides. In that second
phase, the accessible surface of siRNA does not change, supporting
the conclusion that CADY burial is essentially due to the onset of
CADY–CADY interactions and the building of a “CADY cage”. All
together, the binding of the different models of CADYs transforms
the elongated siRNA helix (length of 5–8 nm; width of 2 nm) into
globular complexes of about 7–12 nm (13–38 CADYs).
3.2.2. CADY–siRNA interactions
As expected, the residues implicated in the direct CADY–siRNA
interactions are arginines and the siRNA partners are the phosphate
moieties (Fig. 5). CADYs implicate at least one but never all their argi-
nines in interaction with the siRNA irrespective of the peptide model
used. With the helix model of CADY that displays all the charged res-
idues in the same side, it is the curvature of the siRNA helix that
impairs their simultaneous binding. For the water and interfacial
models that have arginine pointing out in diverse directions, bound
arginines can be from the N-, from the central or from the C-part of
CADY. This together with the numerous phosphate groups of siRNA
Fig. 5. The ﬁrst Cady bound to siRNA in three different complexes. (A) The interfacial Prime model of CADY with siRNA1. (B) The interfacial Prime model of CADY with siRNA2.
(C) The water Prime model of CADY with siRNA1.
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CADY at the surface of siRNA. One particular position is obtained
with siRNA1 that accepts a peptide in its enlarged groove (Fig. 5A)
ensuring both electrostatic interactions of arginine with the phos-
phate in the siRNA crest and more hydrophobic contacts in the
groove. More frequently, CADYs are restricted to external positions
and to electrostatic interactions. They are positioned either in line
with the siRNA phosphate crest or are bridging two crests as in
models B and C of Fig. 5. It is important to notice that arginine-
phosphate salt bridges are “non-selective” of siRNA sequences be-
cause phosphate alignments are in any siRNA sequence.3.2.3. Complex disorder and stability
We have analyzed the evolution of four complexes during molec-
ular dynamic runs (Table 2). These complexes have one and two
layers of CADYs and were made from siRNA2 and from two different
models of CADY, the interfacial PepLook Prime and the α helix. Dur-
ing the dynamic runs, the A form of siRNA2 undergoes small varia-
tions as compared to those of CADY. The nucleic acid helix has a
stretching movement on its length but no unmatching of strands
with deviations of RMS between 0.3 and 0.4 nm (Fig. 6A) essentially
attributed to ﬂuctuations of the major groove widths as evaluated
by measuring the distance between several pairs of phosphates
(Fig. 6B). The mean width is around 1.5 nm and ﬂuctuates between
1 and 2 nm. All bases are and remain matched. The siRNA length, as
evaluated by the distance between P2 and P18 varies between 4
and 5 nm. CADYs remain attached to the phosphates, change confor-
mations but do not tend to insert in grooves. Every CADY has a differ-
ent evolution (Supplementary Fig. S1); some have little variations
with low RMS deviations (0.2–0.3) with respect to the initial confor-
mation, while others have wider movements (RMSD 0.7–0.8)
(Fig. 6A). When the initial model is α helical, CADY conformation is
less changed during the dynamic runs of the one and two layer com-
plexes than when the initial model is the interfacial Prime model of
PepLook (Figs. 6C, 7 and Supplementary Figs. S1–S4). The movements
of CADY in complexes are always more restricted than the move-
ments of CADY in water (Supplementary Fig. S1 to be compared to
Figs. 1 and 2). This supports the idea that in complexes, the move-
ments are restricted in their magnitude and in their direction by theinteractions with the nucleic acid and with the other CADYs. During
the dynamics, the contact surface area between the siRNA and
CADY increases to around 30 nm2 for the complexes with one layer
of CADYs and slightly less for the other complexes. Meanwhile, the
complex water-accessible surfaces decrease (Fig. 6D). These de-
creases are explained partly by the increases of the surface of contact
between siRNA and CADYs and mostly by the increases of the surface
of contact between peptides (Fig. 6D).3.2.4. Energy balance of siRNA–CADYs complexes
To further compare the CADY–siRNA complexes and to evaluate
their evolutions during the dynamics in water, we calculated the
binding energy terms (ΔE (electrostatic) and ΔG (MFP)) taking into
account the cost of partner desolvation and structural changes. We
also evaluated the contact surface areas. During the dynamics, the
ﬂexibility of CADY improves and increases the interaction between
the phosphates and arginines. This results in an increased gain of
electrostatic energy (−280±4 kJ/mol per nm2 for CP1 as compared
to −209±13 kJ/mol per nm2 prior to the dynamics) but essentially
in an increase of the surface of contact between CADYs and siRNA
(42 nm2 for CP1 as compared to 25 nm2 per siRNA prior to dynamics)
(Table 3). Meanwhile, the electrostatic contribution of CADY–CADY
contacts is and remains low (−38±25 kJ/mol per nm2 prior to and
−46±21 kJ/mol per nm2 after the CP1 dynamics). During the molec-
ular dynamics, there is repulsion between R positive charges and only
few of them are within the cut-off of 0.6 nm.
CADY movements also result in an increase of MFP gains due to an
improvement of the complex collapse as demonstrated by the decrease
of the water accessible surface area of both, the one and two layer com-
plexes and, consequently by the increase of the surface of direct con-
tacts between the partners (for CP1, there is a 68% increase for the
siRNA–CADYs contacts and a 282% increase for the CADY–CADYs con-
tacts) (Table 3). The contribution of the CADY–siRNA contacts to the hy-
drophobic collapse is poor (ΔG was only −21±17 kJ/mol per nm2
prior to and is −71±4 kJ/mol per nm2 after the CP1 dynamics). The
contribution of CADY–CADY contacts is larger and depends on the
number of CADYs in the cage. However, expressed by a unit of con-
tact surface, it was 0±259 kJ/mol per nm2 prior to the CP1 dynamics
and is−568±117 kJ/mol per nm2 after the dynamics. This supports
Fig. 6. Evolution of different parameters during the molecular dynamics of the complexes. (A) RMSD calculated on α-carbons and/or phosphorus atoms after a least-square ﬁt on
the initial complex structure. (B) Distances between phosphorus pairs representing the siRNA length (P2–P18), the matching of siRNA base pairs (P2–P39) and the major groove
width (P6–P29). For the sake of clarity, only three pairs are shown. (C) The number of helical residues of CADY averaged over 21 steps computed with DSSP along the trajectories.
(D) Accessible surface of the complex, the siRNA2 and, the contact surface between siRNA2 and CADYs. Graphs from panels A, B and D are derived from the one layer complex made
with the helical model of CADY and siRNA2 (CH1).
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are in the peptide cage.
3.2.5. Detailed analysis of molecule contacts
To further characterize the CADY–siRNA interactions after the mo-
lecular dynamics, atomic contacts were detailed. Fig. 8 gathers the
number of the CADY–siRNA contacts in all the complexes (Fig. 8A
and D) and details their distribution in the one-layer complex made
from the interfacial PepLook model of CADY (CP1, Fig. 8C). CADYs
interact with the siRNA mainly through R residues (53 to 75% of all
the CADY–siRNA contacts in the different complexes) (Fig. 7 and Sup-
plementary Figs. S2–S4). Arginines make salt bridges with the RNA
phosphate groups (52% of the R–siRNA contacts) and hydrogen
bonds with oxygens of sugars and bases (19% of the R–siRNA con-
tacts) (Fig. 8C). Fig. 8D shows that CADYs in the one layer complex
made with the interfacial model of CADY has more contacts with
the nucleotide bases than with sugar, due to more arginine residues
implicated in the H-bonds and Van der Waals interactions. The back-
bone atoms of CADY are also implicated in the H-bonds with siRNA
(30% of all H-bonds). Regarding the position of CADYs on the
siRNA2 surface, no peptide was and has been inserted into the
major groove before and during the dynamics.
The CADY–siRNA interactions also involve hydrophobic and Van der
Waals contacts between amino acid side chains and nucleotide sugar
and bases (9 and 20% of all contacts). These contacts arise mainly in the
minor groove (70%). There is almost no difference between the one and
two layer complexes. More CADY–siRNA interactions are involving W
when complexes are formed from the helix model of the peptide.
Regarding the panel of residues implicated in the CADY/CADY inter-
actions, hydrophobic contacts between the side chains are major (63%
of all the contacts, Fig. 8C) and L and W play a major role (Fig. 8B).
The H-bonds are formed between NH of R andWand backbone carbox-
yl. The cation–π stacking interaction betweenWandR or K of the differ-
ent peptides also arise for 6 (CH1), 13 (CH2), 9 (CP1) and 14% (CP2) of
the W. Comparing the one- and two-layer complexes emphasizes the
increased frequency of the hydrophobic and cation–π stacking
interactions in the larger complex cages. In conclusion to the analysisof the complexes, the 3D conformations of CADYs change during the
dynamics to stabilize the complexes by increasing the electrostatic
contribution of the CADY–siRNA interactions, by enlarging the
hydrophobic collapse of CADYs in the cage and by locking complex
structures with H-bonds and cation–π stacking (Fig. 8E and F). The
main parameters of complexes of similar sizes i.e. the contact ASA per
CADY and per siRNA, the accessible surface of the complexes are similar
irrespective of the initial CADY and siRNA models used.
3.3. Structure–function relationships of complexes
Biological assays have demonstrated that active mixtures of CADYs
and siRNA require a minimum of 10–15 peptides per siRNA [10,14].
According to the modeling data, the 15:1 ratio is a one-layer complex,
thus the 10:1 ratio should be a complex with a partial layer of CADYs.
CADY has 5 positive charges and siRNAs 36 to 40 negative charges;
hence the 10:1 complex is positively charged. Charges could be impor-
tant to locate the complex at the membrane surface and to trigger its
transfer into the cell.
Biological assays have also demonstrated that higher CADYs/siRNA
ratios givemore stable preparations and, ratios of 40:1 and over are op-
timal. Thirty four to thirty eight CADYs make two layers of peptides
around the nucleic acid supporting the conclusion that the experimen-
tal 40:1 ratio corresponds to the two-layer complexes. Again, these
complexes are positively charged. Arginines are numerous at the sur-
face of complexes (Fig. 7 and Supplementary Fig. S4) and charges
should be important for the interactions with the negative charges of
membrane lipids and of cell sugar coats.
This raised the question of the higher stability of larger complexes
with respect to structural parameters. The average MFP value of stable
globular proteins is −271 kJ/mol per aa [53] irrespective of their
folds. The MFP value (kJ/mol per aa) of the CADY cage is never as low
and is at best 63 to 69% of that value. This supports the conclusion
that, even the large CADY cages are not as stable as the proteins. This
could be important to facilitate the dynamic story of the complex,
i.e. its entry and unwrapping in cells. The one and two layer com-
plexes differ in their apparent capacity to adapt to the external
Fig. 7. CADY–siRNA complex after the molecular dynamics (CP2). The complex is the two layer complex made with the Peplook interfacial Prime as the initial CADYmodel. (A) MHP
surfaces of the complex with L and W deﬁned as the length and width of the complex (L=11 nm and W=8 nm). (B) The complex with CADY in a cartoon representation. (C)
Illustration of the peptide cage and the siRNA interface. CADY backbones are cartoons with residue side chains in strings (L, W, K and R). Few arginines pointing towards PO4
are shown in sticks. siRNA atoms are in the sphere representation; Hydrogen and peptide backbone atoms are hidden.
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(hydrophobicity ratios of the two siRNAs are 0.24 and 0.4) is covered
by hydrophobic CADYs. Resulting complexes have similar or higher
(up to 1.4) hydrophobicity ratios than CADY. The hydrophobicity ratio
of 1 is characteristic of the soluble proteins [50]. When complexes are
relaxed by the dynamics in water, the movements of CADY improve
the interactions within the complexes and also the interactions with
the solvent. The hydrophobicity ratios of the complexes with a single
layer of CADYs were 1.22–1.28 before the dynamics and decrease to
1.17–1.18 after the dynamics in water. For the two layer complexes,Table 3
CADY–siRNA complexes before and after the molecular dynamics.
Simulation
namea
Complex
ASA
(nm2)
Hydrophobicity
ratio
Contact surface
with siRNA (nm2)
Contact surface between
peptides (nm2/CADY)b
CP1 (BD) 431 1.22 25 1.7±1.6
CP1 (AD) 290 1.17 42 6.5±1.4
CP2 (BD) 726 1.31 20 3.3±1.7
CP2 (AD) 506 1.07 39 7.3±1.9
CH1 (BD) 403 1.28 20 1.7±1.3
CH1 (AD) 255 1.17 40 7.9±1.6
CH2 (BD) 703 1.27 24 3.7±2.0
CH2 (AD) 488 1.02 34 8.2±2.9
a BD corresponds to complexes prior to dynamics and AD after dynamics.
b Standard deviations are given in brackets.the values were 1.31 and 1.27 and decrease to 1.02 after the dynamics
in water. Hence, the large cage of CADYs seems more efﬁcient to
adapt the cage surface to the water medium.
4. Discussion
Although the therapeutic applications of CPP in the transfer of
non-permeant drugs are promising, the structure of the CPP–cargo
complex and themolecularmechanisms of themembrane translocation
are unclear [7,23,24,55,56]. In this paper we use molecular modelingΔE kJ/mol per
nm2 (with
siRNA)b
ΔG kJ/mol per
nm2 (with
siRNA)b
ΔE kJ/mol per nm2
(between peptides)b
ΔG kJ/mol per nm2
(between peptides)b
−209±13 −21±17 −38±25 0±259
−280±4 −71±4 −46±21 −568±117
−171±13 0±0 −17±21 −38±155
−309±8 −84±8 −67±38 −539±67
−188±8 84±21 −17±21 4±251
−276±4 −75±4 −59±13 −376±113
−167±17 42±38 −13±25 −364±155
−322±13 −146±17 −63±29 −523±79
Fig. 8. Analysis of the CADY–siRNA and CADY–CADY interactions. (A) Number of contacts between CADY and the siRNA per amino acid type and the interaction type. Contacts for
each complex are represented, ﬁrst bars correspond to CH1, second to CH2, third to CP1 and fourth to CP2. (B) Number of contacts between different peptides as a function of the
amino acid type and the interaction type divided by the number of peptides in the complex. (C) Number of contacts between CADY and the siRNA according to their localization
(backbone BK or side chains SC for CADY and phosphate PO4, sugar or base for siRNA) and the interaction type in the one layer complex made with the interfacial PepLook model of
CADY and the siRNA2 (CP1). (D) Contact localization on the siRNA. (E) Number of contacts between CADY and the siRNA per amino acid type before (Hypermatrix) and after mo-
lecular dynamics (MD). (F) Number of contacts between different peptides as a function of the amino acid type before and after the molecular dynamics. The contacts of atoms were
counted using a distance cutoff of 0.35 nm for the ﬁnal structures of the molecular dynamic simulations. ACE and CYA stand for the acetyl and the cysteamide moieties, respectively.
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with its current cargo (siRNA) in water. We screen several options
through the different 3D models of CADY and a range of CADY/siRNA
ratios that cover biological data. In the case of CADY, current biological
assays support that at least 10 to 15 CADYs/siRNA are required to
succeed in a siRNA transfer and, the complexes presenting the best
stability recruit of about 40–80 peptides per siRNA.
Up to now, molecular modeling analyses of CPP were dedicated to
structure predictions [14,33] and to peptide/membrane interactions
[29,31]. The binding of a CPP to a cargo is another, yet the unexplored
process and, complexes were never calculated likely due to the com-
plexity of the task. Indeed, no experimental model of CADY has been
resolved to start from and the complexes are very large. In the discus-
sion, we shall emphasize the essential structural particularities of
CADY, will analyze the complexes obtained from the screening
approach with rigid models and the complexes relaxed by molecular
dynamics to ﬁnally evaluate their common particularities and, the
relevance and limits of our approach.
Regarding structure predictions, the 50 low-energy models of
CADY in water are mainly random coil with similar low MFP values.
There is some differences of the secondary structures but, essentially
large ﬂuctuations of the 3D structures as assessed by their RMSdeviations (around 4 Å). This supports the conclusion that the CADY
structure is poorly self-stable and is in agreement with the structure
ﬂuctuations reported in the experimental evaluations [54]. CADY
forms U shapes in water implicating few hydrophobic residues in a
small core. The U shapes of CADY are hydrophobic further explaining
the poor stability of the peptides in water. The constant hydrophobic-
ity of the CADY models in water is in agreement with the fact that the
peptide inserts in the membranes and we suggest that it explains why
CADYs continue to bind when siRNA is no longer accessible. In those
speciﬁc conditions resulting in the formation of a second layer of pep-
tides, the driving force for the CADY binding cannot be electrostatic. It
should rather be the preference of free CADY for a hydrophobic sur-
face (the one layer CADYs–siRNA complex) than for the water solu-
tion. This should be especially true with the high concentrations of
CADY and siRNA that were used to prepare the vector and might
also explain why the unitary complex further aggregates to form
raspberry-like nanoparticles [50]. The experimental data also report
that CADY helicity increases with the presence of siRNA and mem-
branes [54]. The whole α helix conformation with all arginines on
one side and leucine and tryptophan residues on the opposite side
that we used in one of our series is very amphipathic. Nevertheless,
this α helix model is not found among the 50 best models of PepLook
508 J.-M. Crowet et al. / Biochimica et Biophysica Acta 1828 (2013) 499–509supporting that its probability of occurrence is low, as experimentally
suggested.
It is clear that due to its structural polymorphism, the models of
CADY in solutions are diverse. Moreover, the sequence of CADY is a
repeat of the XLWR motifs where arginine is the binding element to
siRNA giving several possible binding options. On the other side,
siRNA has 36 to 40 phosphate groups that can all be binding targets.
It is clear that expecting a unique model of the complex is utopian
and explains the difﬁculties met in the experimental attempts to
resolve the complex structure. Hence the modeling calculations ap-
pear as an interesting mean to explore the main parameters of the
complex formation. The numerous possibilities make an exhaustive
screening impossible. We chose to use conditions testing a large
panel of possibilities, to start from rigid models of CADY and of siRNAs
and, to go to dynamic movements later on. Indeed, one of the aspects
of our approach is to provide PDB models suitable for running molec-
ular dynamics. Such dynamics would have been impossible from the
free molecules of siRNA and CADY. Nevertheless, the dynamics data
are essential to demonstrate the role of the CADY disorder in the com-
plex stability.
Since the initial binding of CADYs is an electrostatic interaction
with the nucleic acid, eight CADYs could have been sufﬁcient to neu-
tralize the 36–40 phosphates of a molecule of siRNA. We start from
the different 3D models of CADY and ﬁnd that 14±1 peptides are
required to cover the nucleic acid. In Konate et al. 2010, CADY/
siRNA interactions have been titrated and saturation occurs at a
peptide/siRNA molar ratio of 12±2 [14]. Hence, the agreement be-
tween the experimental assays and our data supports that the ap-
proach is relevant and that CADYs do not bind all their arginines.
Finally, the saturation of the siRNA surface generates positively
charged complexes due to the excess of CADY charges. These posi-
tive charges could be important for the attachment of the complex
to the membrane.
The cysteamide residue, which has been shown to improve the
cellular uptake, should not assume a speciﬁc function during the com-
plex building. Though disulﬁde bridges could form between two
cysteamide residues as this has been observed for other cell penetrat-
ing peptides under oxidizing conditions [57,58], CADY remains
monomeric in the solution (data not shown). Moreover, the CADY
peptide with no cysteamide has also been characterized in vitro. It
is as efﬁcient and presents the same properties as CADY with a
cysteamide residue in the solution and in the complexes. The com-
plexes were therefore calculated from the monomeric CADYs.
The complexes were prepared from the three models of CADY, the
Prime model of PepLook in water, in a membrane interface and all the
helix models. In all cases, the electrostatic interactions of the arginine
side chains with the siRNA phosphates are the driving force for the
binding of the ﬁrst layer and the poor implication of the nucleic acid
bases explains the non-selectivity of CADY for siRNA sequences.
The energies of interaction in the complexes were estimated after
taking the cost of the partner desolvation and conformational
changes into account [59]. The values indicate that salt bridges play
the major role in the siRNA–peptide interaction. In the second layer
of complexes, the peptides have no contact with the nucleic acid
and the cage is stabilized by the CADY–CADY hydrophobic interac-
tions. These interactions are clearly optimized by the disorder of
CADY. As discussed before, we also suggest that the binding of the
second layer is triggered by the free peptide hydrophobicity. The cor-
relation between energies of the atom interactions in the complexes
and the biochemical values of afﬁnity, of speciﬁc activity and binding
capacities should be very useful but is not obvious. The dissociation
constant of CADY and siRNA was evaluated at 15–47 nM [10,14]. In
the models, the CADY and siRNA molecules have an optimal surface
of contact around 40 nm2 per complex and an electrostatic energy
gain of −297±21 kJ/mol per nm2. The simulations carried out on
the different complexes converge on the fact that the contact surfacesbetween siRNA–CADY and CADYs increase due to the CADY disorder.
Finally, all the complexes have similar values of the contact surface
and of the energy supporting the conclusion that those values are a
signature of the siRNA–CADY complexes. In addition, the disorder of
CADY facilitates the onset of the H-bonds: such bonds are less ener-
getic than the salt bridges but require precise positions of the
H-donor and acceptor and thus are likely to participate in locking
the 3D structures. Besides the H-bonds, the complexes are also stabi-
lized by the formation of the cation–π stacking interactions between
R and W which are the two constitutive residues of CADY.
The structural polymorphism of CADY is also responsible for the
fact that the accessible surface of the larger complexes can reach
the hydrophobicity ratio value of 1 in water i.e. the standard ratio
value of the soluble proteins [50]. The single layer complexes do not
have this capacity and remain hydrophobic after the dynamic runs.
Movements of CADYs in that single layer must be restricted by the
binding of its polar residues to the siRNA phosphate, whereas in the
second layer, the polar residues of CADYs have less restriction of
movement. This supports the suggestion that a minimal cage of two
layers is necessary for an optimal adaptability of the complexes to
water. It also opens to the suggestion that will be tested in future
studies that a direct uptake of the complexes across the plasma mem-
brane could require the unwrapping of the second layer as proposed
by Konate et al. [14]. This would result in more hydrophobic smaller
complexes and is already supported by the instability of the two
layer complex in a hydrophobic solvent (unpublished data).
In conclusion, we calculated the non-covalent CADY–siRNA com-
plexes by a molecular modeling screening approach and analyzed
their dynamic behavior in water. The arginines of the ﬁrst layer of
peptides bind to the crest of the siRNA phosphate as previously
supported [10,14] and the partner interactions hardly implicate the
nucleic acid bases explaining the absence of selectivity of CADY for
siRNA sequences. Due to the occurrence of several binding residues
per CADY and to the numerous binding targets in siRNA, the structur-
al combination of the CADY positions in siRNA results in numerous
possibilities of the complex structures. Saturating the siRNA accessi-
ble surface with a layer of 12±2 (experimental titration) or 14±1
CADYs (this study) gives hydrophobic though positively charged
one-layer complexes. When the ﬁrst layer of CADYs is bound,
CADYs continue to bind because the peptide is poorly stable in
water. A CADY–siRNA ratio of 40:1, which gives stable therapeutic
vector preparations, leads to complexes with a second layer of
CADYs in which the peptide's spontaneous movements stabilize the
cage by amplifying its hydrophobic collapse and by regulating its in-
teractions with the external partners. The complexes are 7–12 nm
particles, they are much smaller than the 70–80 nm raspberry-like
nanoparticles as seen by electron microscopy [23]. They should how-
ever be the unitary element of those raspberry-like nanoparticles.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2012.09.006.
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